Aptevo Therapeutics
APVO
APVO
13 hedge funds and large institutions have $26.5M invested in Aptevo Therapeutics in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and 7 closing their positions.
Holders
13
Holders Change
-5
Holders Change %
-27.78%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
–
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SC
1
Sessa Capital
New York
|
$4.69M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$1.63M |
| 3 |
3
Millennium Management
New York
|
$813K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
AQR Capital Management
Greenwich,
Connecticut
| – | -$59K | – | – |
|
|
SKK
102
Shepherd Kaplan Krochuk
Boston,
Massachusetts
| – | -$27K | – | – |
|
|
CTC
103
Central Trust Company
Jefferson City,
Missouri
| – | -$2K | – | – |
|
|
HW
104
Hancock Whitney
Gulfport,
Mississippi
| – | -$31K | – | – |
|
|
CS
105
Credit Suisse
Zurich,
Switzerland
| – | -$34K | – | – |
|
106
SG Americas Securities
New York
| – | -$49K | – | – |
|
|
RFS
107
Rockefeller Financial Services
New York
| – | -$64K | – | – |
|